Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Cyclin E1 anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement Cyclin E1 dans WB et IP. Il présente une réactivité envers Humain et Singe.
N° du produit ABIN264331

Aperçu rapide pour Cyclin E1 anticorps (ABIN264331)

Antigène

Voir toutes Cyclin E1 (CCNE1) Anticorps
Cyclin E1 (CCNE1)

Reactivité

  • 155
  • 36
  • 32
  • 2
  • 2
  • 2
  • 2
  • 1
Humain, Singe

Hôte

  • 122
  • 33
  • 1
Souris

Clonalité

  • 105
  • 51
Monoclonal

Conjugué

  • 81
  • 9
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Cyclin E1 est non-conjugé

Application

  • 104
  • 54
  • 46
  • 39
  • 31
  • 28
  • 18
  • 13
  • 11
  • 10
  • 8
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunoprecipitation (IP)

Clone

168
  • Attributs du produit

    Synonyms: Cyclin-E1, CCNE1, CCNE

    Purification

    Purified

    Immunogène

    Recombinant full-length human cyclin E protein.

    Isotype

    IgG2a
  • Indications d'application

    Western Blot: A 50 kDa band corresponding to human cyclin E protein is detected. Immunoprecipitation.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Restrictions

    For Research Use only
  • Buffer

    PBS containing 0.08 % Sodium Azide as preservative.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Store the antibody (in aliquots) at -20 °C. Avoid repeated freezing and thawing.
    Shelf life: One year from despatch.

    Date de péremption

    12 months
  • Antigène

    Cyclin E1 (CCNE1)

    Autre désignation

    Cyclin E1

    Sujet

    Human cyclin E was originally identified by complementation of a triple cln deletion in Saccharomyces cerevisiae. Following the identification of human cyclin E protein, researchers found that breast cancers and some other solid tumors exhibited both quantitative and qualitative alterations in cyclin E protein production. In particular, the alterations in cyclin E expression in breast cancer correlated with increasing stage and grade of the tumor. These results suggested that cyclin E might be useful as a prognostic marker. More recently, Geng et al generated a mouse strain in which the coding sequences for cyclin D1 was deleted and replaced with those of human cyclin E. Replacement of cyclin D1 with cyclin E rescued all phenotypic manifestations seen in the cyclin D1 deficient mice and restored normal development to cyclin D1-dependent tissues. Based on the results of these studies, it appears that cyclin E is the major downstream target of cyclin D1. In addition to functioning downstream of cyclin D1, recent studies with Xenopus egg extracts demonstrated that cyclin E localizes to the centrosome. In these studies CDK2-cyclin E activity was shown to be required for centrosome duplication during S phase. Taken together, these data suggest a mechanism that coordinates centrosome reproduction with cycles of DNA synthesis and mitosis.Synonyms: CCNE, CCNE1, Cyclin-E1

    ID gène

    898

    UniProt

    P24864

    Pathways

    Cycle Cellulaire, Intracellular Steroid Hormone Receptor Signaling Pathway, Nuclear Hormone Receptor Binding, Mitotic G1-G1/S Phases
Vous êtes ici:
Chat with us!